Alkermes (ALKS) Total Current Liabilities (2011 - 2026)

Alkermes' (ALKS) quarterly Total Current Liabilities came in at $599.5 million in Q1 2026, up 35.1% year-on-year from $443.7 million in Q1 2025, and up 10.32% on a QoQ basis from $543.4 million in Q4 2025.

Alkermes (ALKS) Total Current Liabilities (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Total Current Liabilities data on file, last reported at $599.5 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 35.1% year-over-year to $599.5 million in Q1 2026; TTM through Mar 2026 was $599.5 million, a 35.1% increase from a year earlier, with the FY2025 full-year figure at $543.4 million, up 16.82% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $599.5 million, up from $543.4 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ALKS reached as high as $599.5 million in Q1 2026 and fell as low as $438.5 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $490.1 million across 5 years, with a median of $487.2 million in 2023.
  • Across the five-year window, Total Current Liabilities retreated 10.58% in 2024 and soared 35.1% in 2026, its largest moves.
  • Year by year, Total Current Liabilities stood at $497.7 million in 2022, then grew by 4.52% to $520.2 million in 2023, then declined by 10.58% to $465.2 million in 2024, then climbed by 16.82% to $543.4 million in 2025, then rose by 10.32% to $599.5 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $599.5 million in Q1 2026, $543.4 million in Q4 2025, and $474.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn 599.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 599.50 Mn
Dec 31, 2025 543.44 Mn
Sep 30, 2025 474.36 Mn
Jun 30, 2025 505.96 Mn
Mar 31, 2025 443.73 Mn
Dec 31, 2024 465.20 Mn
Sep 30, 2024 453.71 Mn
Jun 30, 2024 515.55 Mn
Mar 31, 2024 458.98 Mn
Dec 31, 2023 520.22 Mn
Sep 30, 2023 503.11 Mn
Jun 30, 2023 487.19 Mn
Mar 31, 2023 492.91 Mn
Dec 31, 2022 497.74 Mn
Sep 30, 2022 469.56 Mn
Jun 30, 2022 438.52 Mn
Mar 31, 2022 462.36 Mn
Dec 31, 2021 471.29 Mn
Sep 30, 2021 452.98 Mn
Jun 30, 2021 383.44 Mn